ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $96,326,900 | $39,625,370 | $37,437,732 | $35,777,486 |
| - Cash | $1,661,454 | $1,236,578 | $1,100,314 | $1,069,296 |
| + Debt | $1,716,165 | $1,668,497 | $1,700,095 | $1,795,595 |
| Enterprise Value | $96,381,611 | $40,057,289 | $38,037,513 | $36,503,785 |
| Revenue | $233,699 | $156,904 | $823,746 | $79,284 |
| % Growth | 48.9% | -81% | 939% | – |
| Gross Profit | $212,049 | $142,878 | $808,688 | $66,894 |
| % Margin | 90.7% | 91.1% | 98.2% | 84.4% |
| EBITDA | -$514,016 | -$528,454 | $229,586 | -$492,672 |
| % Margin | -219.9% | -336.8% | 27.9% | -621.4% |
| Net Income | -$590,768 | -$568,434 | $163,002 | -$523,286 |
| % Margin | -252.8% | -362.3% | 19.8% | -660% |
| EPS Diluted | -1.73 | -1.82 | 0.55 | -1.8 |
| % Growth | 4.9% | -430.9% | 130.6% | – |
| Operating Cash Flow | $0 | $243,034 | -$354,390 | -$357,612 |
| Capital Expenditures | $0 | -$7,762 | -$16,526 | -$12,132 |
| Free Cash Flow | $0 | $235,272 | -$370,916 | -$369,746 |